All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY1203 | Anti-GLI4 (2E8) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2E8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1204 | Anti-GLI4 (3A9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3A9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1205 | Anti-GLI4 (3D5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3D5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1206 | Anti-GLI4 (CBLG1-2817) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2817 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1207 | Anti-GLI4 (CBLG1-2818) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2818 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1208 | Anti-GLI4 (CBLG1-2819) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2819 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2843 | Anti-GLI4(2E8) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2844 | Anti-GLI4(3A9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3A9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2845 | Anti-GLI4(3D5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3D5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2846 | Anti-GLI4(CBLG1-2817) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2817 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2847 | Anti-GLI4(CBLG1-2818) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2818 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2848 | Anti-GLI4(CBLG1-2819) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2819 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION